Skip to content

Trial of mechanical bowel preparation in laparoscopic colorectal surgery with Moviprep

Trial of mechanical bowel preparation in laparoscopic colorectal surgery with Moviprep - TLUMP

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000025815
Enrollment
188
Registered
2017-01-24
Start date
2017-03-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal cancer

Interventions

To take 1L of Asc-PEG + 0.5L of water the day before surgery To take 2L of PEG-ELS the day before surgery

Sponsors

Hokkaido University Graduate School of Medicine, Gastroenterologial Surgery I
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patiens with colorectal cancer who are going to undergo laparoscopic surgery 2. Adenocarcinoma 3. Resectable primary lesion 4. Operative general condition 5. Age between 20 and 85 6. ECOG Performance Status between 0 and 2 7. Adequate informed consent

Exclusion criteria

Exclusion criteria: 1. Obstruction of gastrointestinal tract 2. Perforation of gastrointestinal tract 3. Discharge deficiency of stomach 4. Toxic megacolon 5. Deficiency of G-6-PD 6. Renal failure 7. Severe inflammatory bowel disease 8. Bowel stenosis 9. Disorder of vomiting reflux 10. Dehydration 11. Severe heart or liver disease 12. Anemia owing to tumor bleeding 13. Double cancer 14. Total parenteral nutrition 15. Preoeprative treatment (chemotherapy, radiotherapy, immunothrapy) 16. Uncontrollable diabetes mellitus 17. Severe lung disease 18. Drug allergy 19. Pregnancy 20. Unfitness judged by doctors

Design outcomes

Primary

MeasureTime frame
The availability of bowel irrigation effect confirmed by laparoscope

Secondary

MeasureTime frame
a. Dilatation of small and large bowel b. Duration of bowel preparation c. Duration between the begin of taking Asc-PEG/PEG-ELS and the first evacuation d. Dose of Asc-PEG/PEG-ELS e. Patients' acceptability f. Recover of bowel movement g. Recover of patients' activity h. Conversion rate to open surgery i. Safety j. Postoperative inflammation response k. Differential analysis (tumor location, clinical classification, PS, age, gender,condition of evacuation, condition of taking Asc-PEG/PEG-ELS)

Countries

Japan

Contacts

Public ContactShigenori Homma

Hokkaido University Hospital Gastroenterological Surgery I

homma.s@nifty.com011-706-5927

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026